Report suggests similar effectiveness among options for managing low-risk prostate cancer

A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumour recurrence are similar among the most common treatment approaches, although costs can vary considerably. The report was prepared by the Institute for Clinical and Economic Review (ICER), a leader in comparative effectiveness research based at the Massachusetts General Hospital's Institute for Technology Assessment...

Read the whole article on

More from